Inside The Biotech Startup That Wants To Extend Your Life
Today many scientists who study aging will tell you that people are still looking at longevity in the wrong way. According to Sinclair, that’s partly because currently available drugs are developed to target what he describes as “symptoms of aging,” which include diseases like cancer and heart disease. “People are skeptical that you can change both a person’s healthspan and their life span,” says Dr. Nir Barzilai, director of the Institute for Aging Research at the Albert Einstein College of Medicine and a medical adviser for Life Biosciences.
Source: onezero.medium.com